Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FWQNK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,712
Award facts
- Contract value 100% obligated
- $1,712.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair (omalizumab) 300 mg/2 mL auto-injector vials. This firm fixed-price delivery order, valued at $1,712.23, was awarded on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract carries no set-aside designation and represents a single delivery under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA, valued at $499.999 billion through November 2026.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's existing IDC with the DLA under the SPE2DB program enables the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical product categories supporting military health facilities globally. This particular delivery order for Xolair, a biologic medication used for immunological conditions, exemplifies the company's specialized role in providing specialty pharmaceutical products to military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FWQNK?
SPE2DB25FWQNK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FWQNK worth?
The government has obligated $1,712 on SPE2DB25FWQNK.
Is contract SPE2DB25FWQNK an order under another contract?
Yes. SPE2DB25FWQNK is a delivery order under SPE2DB25D9307, an indefinite delivery contract.
Was contract SPE2DB25FWQNK competed?
The extent of competition for SPE2DB25FWQNK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award